levodopa has been researched along with Akinetic Autism in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (38.46) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 5 (38.46) | 29.6817 |
2010's | 2 (15.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guery, D; Nighoghossian, N; Ong, E | 1 |
Lim, SY; Ng, RX; Tan, AH | 1 |
Shinohara, Y; Takahashi, H | 1 |
Onofrj, M; Thomas, A | 1 |
Jansson, R; Nyholm, D; Remahl, IN; Willows, T | 1 |
Ross, ED; Stewart, RM | 1 |
Berciano, J; Combarros, O; Infante, J | 1 |
Alexander, MP | 1 |
Minderhoud, JM; van Weerden, TW; van Woerkom, TC | 1 |
Bricolo, A | 1 |
Hyland, K; Surtees, R | 1 |
Kurahashi, K; Matsunaga, M; Narita, S; Tanaka, T; Watahiki, Y | 1 |
Patterson, JF | 1 |
1 review(s) available for levodopa and Akinetic Autism
Article | Year |
---|---|
[Diagnosis and therapy for patients with vascular parkinsonism].
Topics: Akinetic Mutism; Amantadine; Antiparkinson Agents; Cerebral Infarction; Dementia, Vascular; Diagnosis, Differential; Gait Disorders, Neurologic; Humans; Levodopa; Muscle Rigidity; Parkinson Disease, Secondary; Platelet Aggregation Inhibitors; Posture; Secondary Prevention; Tremor | 2003 |
12 other study(ies) available for levodopa and Akinetic Autism
Article | Year |
---|---|
Akinetic mutism reversibility after L-dopa therapy in unilateral left anterior cerebral artery infarction.
Topics: Akinetic Mutism; Dopamine Agents; Female; Humans; Infarction, Anterior Cerebral Artery; Levodopa; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Middle Aged | 2017 |
Osmotic Demyelination Syndrome With Evolving Movement Disorders.
Topics: Acute Disease; Adult; Akinetic Mutism; Athetosis; Benserazide; Chorea; Demyelinating Diseases; Dopamine Agents; Drug Combinations; Fluid Therapy; Gastroenteritis; Humans; Hyponatremia; Levodopa; Male; Myelinolysis, Central Pontine; Parkinsonian Disorders; Saline Solution; Time Factors | 2018 |
Acute akinesia in Parkinson disease.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Akinetic Mutism; Apomorphine; Body Temperature; Cohort Studies; Comorbidity; Dopamine Agents; Dose-Response Relationship, Drug; Drug Resistance; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Mortality; Neuroleptic Malignant Syndrome; Parkinson Disease; Prospective Studies; Recovery of Function; Treatment Failure | 2005 |
Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
Topics: Akinetic Mutism; Antiparkinson Agents; Chronobiology Disorders; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Duodenum; Humans; Infusion Pumps; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Sleep Wake Disorders; Time; Time Factors; Treatment Outcome | 2005 |
Akinetic mutism from hypothalamic damage: successful treatment with dopamine agonists.
Topics: Adult; Akinetic Mutism; Bromocriptine; Carbidopa; Ergolines; Humans; Hypothalamic Neoplasms; Hypothalamus; Levodopa; Male; Methylphenidate; Postoperative Complications | 1981 |
Akinetic mutism from frontal lobe damage responding to levodopa.
Topics: Adult; Akinetic Mutism; Dopamine Agents; Female; Frontal Lobe; Humans; Levodopa; Treatment Outcome | 2000 |
Chronic akinetic mutism after mesencephalic-diencephalic infarction: remediated with dopaminergic medications.
Topics: Adult; Akinetic Mutism; Carbidopa; Cerebral Infarction; Chronic Disease; Diencephalon; Dopamine Agents; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Levodopa; Magnetic Resonance Imaging; Mesencephalon; Neuropsychological Tests; Pergolide | 2001 |
On the nature of brain stem disorders in severe head injured patients. II. A study on caloric vestibular reactions and neurotransmitter treatment.
Topics: Akinetic Mutism; Brain Injuries; Brain Stem; Caloric Tests; Child, Preschool; Coma; Consciousness; Humans; Levodopa; Middle Aged; Neurotransmitter Agents; Physostigmine; Time Factors; Vestibular Function Tests | 1976 |
28. The medical therapy of the apallic syndrome.
Topics: Akinetic Mutism; Amino Acids; Amphetamines; Anabolic Agents; Antidepressive Agents; Humans; Levodopa; Muscle Relaxants, Central; Psychotropic Drugs; Vasodilator Agents | 1977 |
L-3,4-dihydroxyphenylalanine (levodopa) lowers central nervous system S-adenosylmethionine concentrations in humans.
Topics: Adolescent; Akinetic Mutism; Biopterins; Child, Preschool; Humans; Infant; Levodopa; Methionine; NADH, NADPH Oxidoreductases; Phenylketonurias; Pyridoxine; S-Adenosylmethionine; Tetrahydrofolates; Tyrosine | 1990 |
[Akinetic mutism from recurrent hydrocephalus: successful treatment with levodopa, bromocriptine and trihexyphenidyl].
Topics: Adult; Akinetic Mutism; Bromocriptine; Drug Therapy, Combination; Humans; Hydrocephalus; Levodopa; Male; Recurrence; Trihexyphenidyl | 1987 |
Akinetic parkinsonism and the catatonic syndrome: an overview.
Topics: Adult; Akinetic Mutism; Benztropine; Carbidopa; Catatonia; Humans; Levodopa; Male; Parasympatholytics; Parkinson Disease; Syndrome | 1986 |